Get the Stockscreener App
28.74
1.00%
-0.31
Legend Biotech Corp Adr stock is traded at $28.74, with a volume of 938.31K.
It is down -1.00% in the last 24 hours and down -16.15% over the past month.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
See More
Previous Close:
$29.05
Open:
$28.88
24h Volume:
938.31K
Relative Volume:
0.66
Market Cap:
$10.56B
Revenue:
$520.18M
Net Income/Loss:
$-348.13M
P/E Ratio:
-14.97
EPS:
-1.92
Net Cash Flow:
$-176.18M
1W Performance:
+3.53%
1M Performance:
-16.15%
6M Performance:
-29.75%
1Y Performance:
-27.19%
1-Day Range:
$28.47
$29.40
1-Week Range:
$27.62
$31.12
52-Week Range:
$27.34
$60.87
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Name
Legend Biotech Corp Adr
Sector
Industry
Phone
-
Address
-
Compare LEGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
28.74 | 5.10B | 520.18M | -348.13M | -176.18M | -1.92 |
|
ONC
Beigene Ltd Adr
|
241.99 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.99 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.78 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.67 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-24 | Initiated | Redburn Atlantic | Buy |
| Jun-17-24 | Initiated | Truist | Buy |
| May-24-24 | Reiterated | H.C. Wainwright | Buy |
| May-23-24 | Initiated | Deutsche Bank | Buy |
| Apr-17-24 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-03-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-13-24 | Initiated | Raymond James | Outperform |
| Dec-19-23 | Initiated | Scotiabank | Sector Perform |
| Nov-06-23 | Initiated | Goldman | Buy |
| May-25-23 | Initiated | William Blair | Mkt Perform |
| May-22-23 | Initiated | Daiwa Securities | Buy |
| Mar-29-23 | Initiated | H.C. Wainwright | Buy |
| Mar-24-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-22 | Initiated | UBS | Buy |
| Nov-02-22 | Initiated | Evercore ISI | Outperform |
| Nov-01-22 | Initiated | Cowen | Outperform |
| Oct-31-22 | Initiated | Guggenheim | Neutral |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Mar-15-22 | Initiated | Barclays | Overweight |
| Jan-31-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-21-21 | Initiated | Piper Sandler | Overweight |
| May-18-21 | Initiated | BTIG Research | Buy |
| Jul-01-20 | Initiated | JP Morgan | Overweight |
| Jul-01-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Morgan Stanley | Overweight |
View All
Legend Biotech Corp Adr Stock (LEGN) Latest News
RBC Capital maintains Legend Biotech at outperform with $78 target By Investing.com - Investing.com South Africa
RBC Capital maintains Legend Biotech at outperform with $78 target - Investing.com
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday - Investing.com
Legend Biotech stock holds $62 target, solid Carvykti sales growth By Investing.com - Investing.com India
Legend Biotech stock holds $62 target, solid Carvykti sales growth - Investing.com
Truist cuts Legend Biotech stock target to $71, maintains buy rating - Investing.com India
Raymond James maintains Legend Biotech Outperform rating - Investing.com
Raymond James maintains Legend Biotech Outperform rating By Investing.com - Investing.com UK
Earnings call transcript: Legend Biotech Q1 2025 sees strong CARVICTI sales boost - Investing.com India
Legend Biotech Q1 2025 slides: CARVYKTI sales surge 135% as path to profitability clarifies - Investing.com India
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - GlobeNewswire Inc.
Stock Surge: Legend Biotech Corp ADR (LEGN) Closes at 31.37, Marking a -6.08 Increase/Decrease - DWinneX
What Makes Legend Biotech (LEGN) a New Buy Stock - Yahoo Finance
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet - Yahoo Finance
Top investors say Legend Biotech Corp ADR (LEGN) ticks everything they need - Sete News
LEGN stock rated a Buy by Redburn Atlantic - knoxdaily.com
Taking a look at what insiders are doing to gauge the Legend Biotech Corp ADR (LEGN)’s direction - knoxdaily.com
Selling Buzz: Graphjet Technology [GTI] 10% Owner SURIA SUKSES ENGINEERING SDN B sells 2,490,517 shares of the company – Knox Daily - knoxdaily.com
UP Fintech Holding Ltd ADR [TIGR] Records 200-Day SMA of $6.22 - knoxdaily.com
UEC Stock Sees Surge of Approximately 9.34% in Last Five Days - knoxdaily.com
Vir Biotechnology Inc [VIR] Records 200-Day SMA of $8.24 - knoxdaily.com
Arm Holdings plc. ADR [ARM] Officer makes an insider purchase of 9,220 shares worth 1.41 million. - knoxdaily.com
Valero Energy Corp [VLO] Records 200-Day SMA of $134.80 - knoxdaily.com
KE Holdings Inc ADR [BEKE] Records 200-Day SMA of $18.54 - knoxdaily.com
Celestica, Inc [NYSE: CLS] Sees Increase in Stock Value - knoxdaily.com
Perimeter Solutions Inc [PRM] Records 50-Day SMA of $9.97 - knoxdaily.com
JBI Shares Experience Surge in Value - knoxdaily.com
CRGY Shares Experience Surge in Value - knoxdaily.com
Gannett Co Inc [GCI] Records 200-Day SMA of $4.65 - knoxdaily.com
Jamf Holding Corp [JAMF] Shares Rise 5.68 % on Thursday - knoxdaily.com
Mirion Technologies Inc [MIR] Records 200-Day SMA of $13.95 - knoxdaily.com
Vista Energy S.A.B. de C.V ADR [NYSE: VIST] Sees Increase in Stock Value - knoxdaily.com
Ares Management Corp [ARES] stock for 16,977,649 USD was sold by Arougheti Michael J - knoxdaily.com
Banc of California Inc [BANC] Records 50-Day SMA of $13.98 - knoxdaily.com
HSAI Shares Experience Surge in Value - knoxdaily.com
QXO Stock Sees Decline of Approximately -10.59% in Last Five Days - knoxdaily.com
Blue Owl Capital Inc [OWL] Controlled affiliate makes an insider purchase of 1,817,382 shares worth 39.13 million. - knoxdaily.com
Lennar Corp [NYSE: LEN] Sees Increase in Stock Value - knoxdaily.com
Vertiv Holdings Co [NYSE: VRT] Sees Increase in Stock Value - knoxdaily.com
XPeng Inc ADR [XPEV] Records 200-Day SMA of $13.46 - knoxdaily.com
Zurn Elkay Water Solutions Corp [NYSE: ZWS] Sees Increase in Stock Value - knoxdaily.com
Pegasystems Inc [PEGA] Shares Jump Approximately 57.05% Over the Year - knoxdaily.com
A company insider recently sold 50,000 shares of Iovance Biotherapeutics Inc [IOVA]. Should You Sale? - knoxdaily.com
Cameco Corp [CCJ] Officer makes an insider purchase of 50,000 shares worth 3.06 million. - knoxdaily.com
Sea Ltd ADR [SE] Shares Rise 3.14 % on Thursday - knoxdaily.com
Rithm Capital Corporation [RITM] Shares Rise 0.68 % on Thursday - knoxdaily.com
Carpenter Technology Corp [NYSE: CRS] Sees Increase in Stock Value - knoxdaily.com
Taking a look at what insiders are doing to gauge the Sandstorm Gold Ltd (SAND)’s direction - knoxdaily.com
A company insider recently sold 50,896 shares of OppFi Inc [OPFI]. Should You Sale? - knoxdaily.com
Taking a look at what insiders are doing to gauge the AMC Entertainment Holdings Inc [AMC]’s direction - knoxdaily.com
Legend Biotech Corp Adr Stock (LEGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
17.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):